Is AB Science SA halal to invest in?

According to Musaffa's Shariah screening methodology, AB Science SA (AB.PA) is currently classified as NOT HALAL as of December 2025. The classification is based on an evaluation of the company's business activities and financial ratios to determine whether it meets Islamic investment guidelines.

Is AB Science SA a Shariah-compliant stock?

A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes AB Science SA using these criteria to determine its compliance status.

Can Muslims buy shares of AB Science SA?

Muslim investors may consider investing in AB Science SA if it meets Shariah compliance standards. Investors typically review the company's business activities, debt levels, and non-permissible income before making a decision.

Why is AB Science SA classified as NOT HALAL?

Musaffa determines the Shariah status of AB Science SA by analyzing whether the company's core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.

How often is the Shariah compliance for AB Science SA updated?

The Shariah compliance status of AB Science SA may be updated periodically when new financial statements, earnings reports, or business activity information become available.

Can a halal stock like AB Science SA become non-compliant?

Yes. A stock that is currently Shariah-compliant may become non-compliant if the company's financial ratios exceed Shariah thresholds or its business activities change.

Where can I check the Shariah status of AB Science SA?

You can check the latest Shariah compliance status of AB Science SA on Musaffa's stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.

AB Science SA AB.PA

€1.00 €0.02 (2.16%) 1D

Last Updated: May 15, 12:00 AM·XPAR

AB.PA Shariah Compliance

Screening Methodology: AAOIFI

NOT HALAL

Last Updated: December 30, 2025

Report Source: 2025 2nd Quarter Report

AB Science SA. Stock Analysis AB.PA

France Health Care Micro Cap Report: Q2, 2025

AB Science SA operates as a pharmaceutical company, which engages in the research, development, and marketing of synthetic therapeutic molecules for pathologies with high medical need, in diseases of the central nervous system, cancers, and inflammatory diseases. The company is headquartered in Paris, Ile-De-France and currently employs 37 full-time employees. The company went IPO on 2010-04-21. The company is engaged in targeted therapies through tyrosine kinase inhibitors for treating diseases with high medical factor in the field of cancer, chronic inflammatory diseases, neurological degenerative disorders and central nervous systems diseases in both human and veterinary medicine. The main focus of the Company is the development of tyrosine kinase inhibitors, for instance Masitinib which is a tyrosine kinase inhibitor used as a veterinary medicine in the treatment of canine mast cell tumors. The firm is present in the United States and Europe. As of December 31, 2013, the Company operated though a subsidiary, AB Science USA LCC, based in the United States.

Key Statistics of AB Science SA (AB.PA)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

€0.99€1.04

Today's Open

€1.02

Volume

413.82K

P/E Ratio (TTM)

52 Week Range

€0.93€1.73

Market Cap

66.18M

Avg. Volume

91.22K

Dividend Yield

Financial Metrics & Statements of AB Science SA (AB.PA)

FAQ's for AB Science SA (AB.PA)

According to Musaffa’s Shariah screening methodology, AB Science SA (AB.PA) is currently classified as NOT HALAL as of December 2025. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.